期刊文献+

冠状动脉药物涂层支架后再狭窄与炎症反应的相关性 被引量:1

Relationship Between Restenosis After Implantation of Drug-eluting Stent and Inflammatory Reaction
下载PDF
导出
摘要 药物涂层支架的应用使冠心病的介入治疗有了长足进展,但是支架再狭窄仍是不容忽视的问题。现就支架后的炎症反应和再狭窄的关系,药物涂层支架对于抑制炎症和降低再狭窄发生率的作用机理进行综述。 Since the introduction of the bare-metal stent, the drug-eluting stent has made major developments in percutaneous coronary intervention in the treatment of obstructive coronary artery disease. However, long term success of percutaneous coronary intervention is in- hibited by neointimal hyperplasia occurring within the stent leading to in-stent restenosis. This article reviews the relationship between in- stent restenosis and the inflammatory reaction after stenting, and the mechanism for the drug-eluting stent to inhibit the inflammation and de- crease the rate of in-stent restcnosis.
出处 《心血管病学进展》 CAS 2009年第5期791-794,共4页 Advances in Cardiovascular Diseases
关键词 经皮冠状动脉介入术 药物涂层支架 再狭窄 炎症反应 percutaneous coronary intervention drug-eluting stent restenosis inflammatory reaction
  • 相关文献

参考文献22

  • 1Bennett MR.In-stent restenosis.Pathology and implications for the development of drug eluting stent[J].Heart,2003,89:214-218.
  • 2Ortolant P,Ardissino D,Cavallini C,et al.Effect of sirolimus-eluting stent in diabetic patients with small coronary arteries (a SES-SMART substudy)[J].Am J Cardiol,2005,96:1393-1398.
  • 3Schofer J,Schluter M,Gershlick AH,et al.Sirolimus-eluting stent for treatment of patients with long atherosclerotic lesions in small coronary arteries,double-blind,randomized controlled trial (E-SIRIUS)[J].Lancet,2003,362:1093-1099.
  • 4Rodriguez-Granillo GA,Valgimigli M,Garcia-Garcia HM,et al.One-year clinical outcome after coronary stenting of very small vessels using 2.25mm sirolimus-and paclitaxel-eluting stents a comparison between the RESEARCH and TSEARCH registries[J].J Invasive Cardiol,2005,17:413-414.
  • 5Nuhrenberg TG,Voisard R,Fahlisch F,et al.Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty[J].FASEB J,2005,19:246-248.
  • 6Adkins JR,Castresana MR,Wang Z,et al.Rapamycin inhibits release of tumor necrosis factor-alpha from human vascular smooth muscle cells[J].Am Surg,2004,70:384-387.
  • 7Welt FG,Tso C,Edelman ER,et al.Leukocyte recruitment and expression of chemokines following different forms of vascular injury[J].Vasc Med,2003,8:1-7.
  • 8Li JJ,Fang CH,Jiang H,et al.Time course of inflammatory response after renal artery stenting in patients with atherosclerotic renal artery stenosis[J].Clin Chim Acta,2004,350:115-121.
  • 9Aggarwal A,Blum A,Schender DJ,et al.Soluble CD40 ligand is an early initiator of inflammation after coronary intervention[J].Coron Artery Dis,2004,15:472-475.
  • 10Gach O,Biemar C,Nys M,et al.Early release of neutrophil markers of activation after direct stenting in patients with unstable angina[J].Coron Artery Dis,2005,16:59-65.

同被引文献46

  • 1赵慧强,郭文怡,贾国良,秦涛,李虎,梁军,王音,王晓燕.雷帕霉素洗脱支架对冠心病患者介入术后血炎症因子的影响[J].中国循环杂志,2005,20(2):98-101. 被引量:7
  • 2李晓涛,夏岳.炎症反应在冠脉支架置入术后再狭窄中的研究进展[J].心血管病学进展,2007,28(5):703-706. 被引量:12
  • 3Riezebos RK, Verheugt FW, Laarman G J, et aI.The biochemical aspects of a non-ST-segment elevation acute coronary syndrome. Rev Cardiovasc Med. 2012; 13(2-3):e70-e76.
  • 4Jukema JW, Verschuren J J, Ahmed TA,et al. Restenosis after PCI. Part 1: pathophysiology and risk factors. Nat Rev Cardiol 2011 ;9(1 ):53-62.
  • 5Sun D, Zheng Y, Yin T, et al. Coronary drug-eluting stents: from design optimization to newer strategies. J Biomed Mater Res A. 2014;102(5):1625-1640.
  • 6庞明杰,张宏,赵燕,等.依维莫司洗脱支架在急性冠脉综合征中应用的效果分析[J].医学前沿,2013,4:20-21.
  • 7Anderson JL, Adams CD, Antman EM, et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the american college of cardiology foundation/american heart association task force on practice guidelines. Circulation. 2012,126(7):875-910.
  • 8Ramasamy I. Biochemical markers in acute coronary syndrome, Ctin Chim Acta. 2011 ;412(15-16): 1279-1296.
  • 9Sami S, Willerson JT. Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 2). "rex Heart Inst J. 2010;37(3):262-275.
  • 10Koenig W. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy. Int J Cardiol. 2013:168(6:5126-5134.

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部